EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neoadjuvant Therapy for Melanoma

Michael C Lowe, Ragini R Kudchadkar

Surgical Oncology Clinics of North America · 2020-07 · 29 (3) · 445-453

DOI: 10.1016/j.soc.2020.03.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2020-07. Verfasst von Michael C Lowe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Emory University School of Medicine, 1365 Clifton Road, Atlanta, GA 30322, USA. Electronic address: mlowe3@emory.edu. Hauptthemen laut MEDLINE: Molecular Targeted Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the universal adoption of immune checkpoint blockade and agents targeting BRAF-mutated melanomas in the metastatic setting, numerous clinical trials have evaluated these agents in the neoadjuvant setting. These smaller trials have shown promising results with high pathologic response rates and acceptable safety. Larger prospective randomized trials are under way to determine if all patients with resectable metastatic disease should be receiving neoadjuvant therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Targeted TherapyAntineoplastic AgentsChemotherapy, AdjuvantHumansMelanomaNeoadjuvant TherapySkin Neoplasms

Stichwörter der Autor:innen

ImmunotherapyMelanomaNeoadjuvantTargeted therapy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Surgery, Emory University School of Medicine, 1365 Clifton Road, Atlanta, GA 30322, USA. Electronic address: mlowe3@emory.edu.
  • Department of Hematology and Oncology, Winship Cancer Institute, 1365 Clifton Road, Atlanta, GA 30322, USA.

Zitieren

APA

Lowe, M. C., & Kudchadkar, R. R. (2020). Neoadjuvant Therapy for Melanoma. Surgical Oncology Clinics of North America, 29(3), 445-453. https://doi.org/10.1016/j.soc.2020.03.001

Vancouver

Lowe MC, Kudchadkar RR. Neoadjuvant Therapy for Melanoma. Surgical Oncology Clinics of North America. 2020;29(3):445-453. doi:10.1016/j.soc.2020.03.001

BibTeX
@article{Lowe2020,
  author = {Lowe, Michael C and Kudchadkar, Ragini R},
  title = {Neoadjuvant Therapy for Melanoma},
  journal = {Surgical Oncology Clinics of North America},
  year = {2020},
  volume = {29},
  number = {3},
  pages = {445--453},
  doi = {10.1016/j.soc.2020.03.001}
}
Kostenlos starten →